Apex Biologics Consulting provides expert support to companies looking to develop novel biologics. It specialises in advising on the integrated technical development of all major classes of biologic medicines, including monoclonal antibodies (including fAbs and scFvs), PEGylated proteins and growth factors, as well as antibody drug conjugates and biosimilars.
Transitioning a new molecule through the clinic is a complex venture requiring high investment and an integrated approach to clinical supply, development of the pharmaceutical form, non-clinical evaluation to support the first dosing and technical development to reach the right quality for the right price. Investment in a sound programme of development ensuring full developability, minimising liabilities and knowing where and when to invest in CMC activities (especially avoiding unnecessary activities) is crucially important and this is where I can help.
I am passionate about developing state-of-the art medicines and it is my pleasure to offer the following support services: